In 2011, Yavuz et al. [52] demonstrated that HCQ may alleviate the signs and symptoms of dry eyes in pSS and decrease tear fluid B-cell activator factor (BAFF) levels. This evidence concerns the gene TNFSF13B and Keratoconjunctivitis sicca.